SCHEMBL23446026

SCHEMBL23446026

CC1(C)CCC(C)(C)c2cc(Nc3ccc4c(c3-c3ccccc3)C(C)(C)CCC4(C)C)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 11/20 0.41
▸ RARG P13631 10/20 0.41
▸ RARA P10276 9/20 0.41
▸ CYP26A1 O43174 5/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ PGR P06401 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ TBXA2R P21731 1/20 0.40
▸ BLVRB P30043 1/20 0.40
▸ RXRA P19793 5/20 0.38
▸ CYP1A2 P05177 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ CYP26B1 Q9NR63 3/20 0.37
▸ HNF4A P41235 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23445601 0.80 RARB (0.43) RARBRARGRARACYP26A1MEN1
SCHEMBL29945232 0.80 RARB (0.46) RARBRARGRARACYP26A1MEN1
SCHEMBL23442800 0.80 RARB (0.46) RARBRARGRARACYP26A1MEN1
SCHEMBL26306822 0.79 RARB (0.52) RARBRARGRARACYP26A1MEN1
SCHEMBL23927600 0.79 CYP26A1 (0.42) RARBRARGRARACYP26A1MEN1
SCHEMBL31375685 0.79 RARB (0.51) RARBRARGRARACYP26A1MEN1
SCHEMBL27395133 0.79 RARB (0.51) RARBRARGRARACYP26A1MEN1
SCHEMBL25491015 0.79 RARB (0.51) RARBRARGRARACYP26A1MEN1
SCHEMBL24561522 0.78 RARB (0.46) RARBRARGRARACYP26A1MEN1
SCHEMBL26006715 0.77 RARB (0.50) RARBRARGRARACYP26A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780856-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-10-10 — — US disclosed
US-11780856-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-10-10 — — US disclosed
EP-3919500-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-12-08 — — EP disclosed
WO-2021107681-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2021-06-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780856-B2 Compound and organic light-emitting device comprising same CRY1, CRY2, LEF1 RARB 1767/4885RARG 1720/4885RARA 992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback